![Pavan Cheruvu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pavan Cheruvu
No open positions remaining
Net worth: 2 M $ as of 31/08/2026
Profile
Dr. Pavan K.
Cheruvu, MD, is a Chairman at Imbria Pharmaceuticals, Inc. and a Chief Executive Officer & Director at Amanat Acquisition Corp.
He is on the Board of Directors at Amanat Acquisition Corp.
Dr. Cheruvu was previously employed as a President, Chief Executive Officer & Director by Sio Gene Therapies, Inc., a Chief Executive Officer by Axovant Sciences, Inc., and a President, Chief Executive Officer & Director by Bitterroot Bio, Inc. He received his undergraduate degree from Duke University, a graduate degree from the University of Oxford and a doctorate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
6.9% | 20/05/2026 | 150,000 ( 6.9% ) | 2 M $ | 31/08/2026 |
Pavan Cheruvu active positions
| Companies | Position | Start |
|---|---|---|
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Chairman | 01/09/2025 |
Former positions of Pavan Cheruvu
| Companies | Position | End |
|---|---|---|
Bitterroot Bio, Inc.
 Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Chief Executive Officer | 01/02/2026 |
| SIO GENE THERAPIES INC. | Chief Executive Officer | 31/01/2022 |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Chief Executive Officer | 01/12/2020 |
Training of Pavan Cheruvu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
39
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Health Technology |
- Stock Market
- Insiders
- Pavan Cheruvu
